Biotechnology

Filter

Current filters:

None

Popular Filters

1880 to 1904 of 2404 results

FDA backs Medivation and Astellas' prostate cancer drug Xtandi

03-09-2012

USA-based Medivation (Nasdaq: MDVN and Japanese drug major Astellas Pharma (TYO: 4503) say that the US…

Astellas PharmaBiotechnologyenzalutamideMedivationNorth AmericaOncologyPharmaceuticalRegulationXtandi

UK biotech calls for "mass market" citizens' innovation funds

03-09-2012

The outlook for the UK economy remains flat and innovative small- and medium-sized enterprises (SMEs)…

BiotechnologyEuropeFinancialResearch

EMA starts consultation on children's medicines with cadiovasculars

02-09-2012

The European Medicines Agency has begun its first public consultation on its inventory of medicines for…

BiotechnologyCardio-vascularEuropeHealthcarePharmaceuticalRegulation

Genmab leaps on $1.1 billion daratumumab deal with Janssen

31-08-2012

Denmark's Genmab A/S (OMX: GEN) saw its shares leap 20% to 81 Danish kroner in morning trading yesterday,…

BiotechnologydaratumumabFinancialGenmabHuMax-CD38JanssenJohnson & JohnsonLicensingOncologyPharmaceutical

Bayer files NDA for regorafenib for the treatment of GIST

31-08-2012

The US subsidiary of Germany's Bayer (BAYB: DE) has submitted a New Drug Application to the US Food and…

BayerBiotechnologyNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalregorafenibRegulation

Abbott's Humira cleared for Crohn's disease in EU

31-08-2012

The European Commission has approved US health care major Abbott Laboratories' (NYSE: ABT) blockbuster…

Abbott LaboratoriesAnti-Arthritics/RheumaticsBiotechnologyEuropeGastro-intestinalsHumiraPharmaceuticalRegulation

Prana Parkinson's drug meets development milestone

30-08-2012

Australia's Prana Biotechnology (ASX: PBT) ,says that its lead compound in development for Parkinson's…

BiotechnologyNeurologicalPBT434Prana BiotechnologyResearch

Australian Productivity Commission reviews compulsory licensing in the patents system

30-08-2012

The Australian Productivity Commission's review into compulsory licensing in the patents system is now…

Asia-PacificBiotechnologyLicensingPatentsPharmaceutical

QPS buys majority of Austria's largest independent CRO

29-08-2012

In a second European acquisition, USA-based QPS, a full-service GLP/GCP-compliant contract research organization,…

BiotechnologyJSW Life SciencesMarkets & MarketingPharmaceuticalQPS HoldingsResearch

Gilead's Stribild, formerly "Quad," gets FDA nod

29-08-2012

The US Food and Drug Administration has approved US biotech firm Gilead Sciences' (Nasdaq: GILD) Stribild…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaQuadRegulationStribild

Pharmaceutical sales rep access reducing most among oncologists in USA

28-08-2012

As more pharmaceutical companies prepare to bring new oncology drugs to market, their sales representatives…

BiotechnologyManagementMarkets & MarketingNorth AmericaOncologyPharmaceutical

FDA calls on Genzyme to re-file Lemtrada sBLA

28-08-2012

French drug major Sanofi (Euronext: SAN) revealed yesterday that its US biotech subsidiary has received…

BayerBiotechnologyGenzymeLemtradaNeurologicalNorth AmericaPharmaceuticalRegulationSanofi

Synergy Pharma gains rights to shingles drug from Bristol-Myers

28-08-2012

US biopharma firm Synergy Pharmaceuticals (Nasdaq: SGYP) has signed an asset purchase agreement with…

Anti-viralsBiotechnologyBristol-Myers SquibbFV-100Mergers & AcquisitionsSynergy Pharmaceuticals

Cancer treatments top breakthrough medicines list, Australian study finds

27-08-2012

A cure for cancer is still to be found but more new treatments have been approved for Australians with…

Asia-PacificBiotechnologyHealthcareMarkets & MarketingPharmaceuticalResearch

Bristol-Myers drops hep C pill on patient safety issues

24-08-2012

US drug major Bristol-Myers Squibb (NYSE: BMY) has discontinued development of BMS-986094 (formerly known…

Anti-viralsBiotechnologyBMS-986094Bristol-Myers SquibbPharmaceuticalRegulationResearch

Pharming first-half 2012 net loss nearly doubles

24-08-2012

Netherlands-based biotech company Pharming (NYSE Euronext: PHARM), which recently revealed that it is…

BiotechnologyFinancialPharming

Gilead abandons development of PAH drug cicletanine

23-08-2012

US biotech firm Gilead Sciences (Nasdaq: GILD), the world leader in HIV/AIDS drugs, has discontinued…

BiotechnologycicletanineGilead SciencesRare diseasesResearchRespiratory and Pulmonary

Australia's BTWG opens discussion on cuts to R&D Tax Incentive

23-08-2012

The Australian Business Tax Working Group (BTWG) has issued a discussion paper, which includes amongst…

Asia-PacificBiotechnologyFinancialPharmaceuticalResearch

1880 to 1904 of 2404 results

Back to top